Thynk Capital
Venture capitalPre-Seed–Series A · 1 people tracked
Investment thesis
Thynk Capital backs early-stage companies in therapeutics, healthcare, and technology, providing growth capital alongside hands-on operational support to optimize performance and build enterprise value. The firm works collaboratively with portfolio companies to improve efficiencies, strengthen management teams, and develop growth roadmaps. It is expanding into early-stage pharma and biotech focused on extending healthspan and addressing major diseases of aging such as Alzheimer's, dementia, kidney disease, cancer, cardiovascular disease, diabetes, frailty, and rare disease. The firm emphasizes its top-percentile historical venture performance and positions itself at the forefront of technology-driven innovation.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from the firm's websiteEntrepreneur, inventor and investor with over 30 years of experience in technology, healthcare and biotechnology, and nearly 20 years investing in early-stage tech and life science companies. He founded Klotho Therapeutics, Pathway Genomics, E-Band Communications and SmartDrive Systems, led the turnaround of Beltronics, and served on the U.S. Industry Trade Advisory Committee (2015-2018).
What they invest in
from 2 of 17 portfolio companiesBiotech ×1Enterprise Software ×1IoT ×1Logistics & Supply Chain ×1Medical Devices ×1SaaS ×1
Investments · 17 tracked
founders shown can be your intro pathSmartDrive Systems provides video-based fleet safety and analytics solutions for commercial transportation companies, including trucking fleets and transit systems, to prevent collisions and improve driver performance.
Enterprise SoftwareIoTLogistics & Supply ChainSaaS
X4 Pharmaceuticals develops medicines for people living with rare immune disorders, including treatments for chronic neutropenia.
BiotechMedical Devices
Frequently asked questions
- What stage does Thynk Capital invest at?
- Thynk Capital invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Thynk Capital focus on?
- Thynk Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
Similar investors
Medical Excellence Capital (MEC) is an early-stage life science venture fund founded in 2020 by patients for patients, backing therapeutics, diagnostics, and medical technology companies.
Overwater Ventures is an early-stage investor backing companies redefining everyday experiences, investing at pre-seed and seed stages.
PsyMed Ventures is an early-stage venture firm investing in neuroscience and frontier technologies aimed at improving brain and mental health.
Seed Healthcare invests in and advises healthcare startups focused on early disease detection and prevention, providing capital, technology implementation, and advisory services across investment, sales growth, and provider strategy.
Rising Tide is a venture capital firm investing in innovation across healthcare, life sciences, AI, space, and other deep technology sectors.